Prospera Financial Services Inc Amarin Corp Plcuk Transaction History

Prospera Financial Services Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.66 - $0.91 $7,210 - $9,941	10,925 New	10,925 $9,000
Q2 2022 Aug 08, 2022	SELL	$1.13 - $3.69 $4,705 - $15,365	-4,164 Reduced 30.8%	9,357 $14,000
Q1 2022 May 04, 2022	BUY	$2.85 - $3.73 $3,847 - $5,035	1,350 Added 11.09%	13,521 $44,000
Q4 2021 Feb 10, 2022	SELL	$3.24 - $5.18 $10,449 - $16,705	-3,225 Reduced 20.95%	12,171 $41,000
Q3 2021 Nov 12, 2021	SELL	$3.94 - $5.84 $1,773 - $2,628	-450 Reduced 2.84%	15,396 $79,000
Q2 2021 Aug 12, 2021	BUY	$4.26 - $6.5 $67,503 - $102,999	15,846 New	15,846 $69,000
Q4 2020 Feb 12, 2021	SELL	$4.04 - $5.31 $2,585 - $3,398	-640 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$3.64 - $7.76 $2,329 - $4,966	640 New	640 $3,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $214M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.